These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 4538438)
1. [Inhibition of the thromboplastic effect of placental extracts using trasylol]. Slunsky R Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438 [No Abstract] [Full Text] [Related]
2. [Trasylol as inhibitor of the thromboplastic effect of amniotic fluid and placental extracts]. Slunsky R Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):338-45. PubMed ID: 4123098 [No Abstract] [Full Text] [Related]
3. [Coagulation inhibiting effect of Trasylol]. Slunsky R Z Geburtshilfe Gynakol; 1971 Aug; 175(1):55-61. PubMed ID: 5315177 [No Abstract] [Full Text] [Related]
4. [Inhibition of the thromboplastic activity of amniotic fluid with Trasylol]. Slunsky R Gynakol Rundsch; 1973; 13(2):147-52. PubMed ID: 4542664 [No Abstract] [Full Text] [Related]
5. [The effect of amino-methyl-cyclohexane-carboxylic acid (AMCHA) in activated hemostasis]. Pfeifer GW; Dietz M Zentralbl Gynakol; 1969 Oct; 91(40):1292-5. PubMed ID: 5308573 [No Abstract] [Full Text] [Related]
6. [Diagnosis and treatment of obstetric thrombohemorrhagic syndrome]. Grigorian AA; Avanesian RM; Melkonian VK Zh Eksp Klin Med; 1974; 14(4):96-103. PubMed ID: 4547478 [No Abstract] [Full Text] [Related]
7. Inhibition of thromboplastic activity by Trasylol. In vitro investigations concerning the mechanism of inhibition. Amris CJ; Hilden M Scand J Haematol; 1967; 4(1):3-10. PubMed ID: 5298445 [No Abstract] [Full Text] [Related]
8. [Disorders of coagulation and hemostasis during pregnancy and labor]. Chrobák L; Radocha K Cesk Gynekol; 1968 Oct; 33(8):616-9. PubMed ID: 5304122 [No Abstract] [Full Text] [Related]
9. Anticoagulant effects of Trasylol: in vitro and in vivo studies. Amris CJ; Hilden M Ann N Y Acad Sci; 1968 Jun; 146(2):612-24. PubMed ID: 5306290 [No Abstract] [Full Text] [Related]
10. Tissue factor-induced coagulation can be inhibited by aprotinin (Trasylol). van den Besselaar AM; Dirven R; Bertina RM Thromb Haemost; 1993 Mar; 69(3):298-9. PubMed ID: 7682341 [No Abstract] [Full Text] [Related]
11. [Present prospects in the diagnosis and treatment of obstetrical blood coagulation disorders]. Dambrosio F; Bellati U; Capetta P Minerva Ginecol; 1968 Oct; 20(19):1596-600. PubMed ID: 5308999 [No Abstract] [Full Text] [Related]
12. [On the modification of postoperative blood circulation and coagulation changes with the proteinase inhibitor trasylol]. Haberland GL; Matis P; Pauschinger P; Thies HA; Vinazzer H Med Welt; 1969 May; 22():1270-5. PubMed ID: 5306519 [No Abstract] [Full Text] [Related]
13. Inhibition of thromboplastin-induced intravascular coagulation by heparin and Trasylol. Nordström S Acta Physiol Scand; 1970 Jul; 79(3):390-404. PubMed ID: 5311148 [No Abstract] [Full Text] [Related]
14. Studies on the anticoagulant action of aprotinin ("trasylol"). Prentice CR; Mcnicol GP; Macnicol GP; Douglas AS Thromb Diath Haemorrh; 1970 Oct; 24(1):265-72. PubMed ID: 5312434 [No Abstract] [Full Text] [Related]